Autolus Therapeutics (AUTL) Total Liabilities (2017 - 2026)
Autolus Therapeutics' (AUTL) quarterly Total Liabilities came in at $410.9 million in Q4 2025, up 15.63% YoY from $355.4 million in Q4 2024, and up 3.64% on a QoQ basis from $396.5 million in Q3 2025.
Autolus Therapeutics (AUTL) Total Liabilities (2017 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 9 years of Total Liabilities data on file, last reported at $410.9 million in Q4 2025.
- Quarterly Total Liabilities rose 15.63% year-over-year to $410.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $410.9 million (up 15.63% YoY) and the FY2025 annual result came in at $410.9 million, up 15.63% from the prior year.
- Total Liabilities climbed to $410.9 million in Q4 2025, from $396.5 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $410.9 million in Q4 2025 to a low of $47.0 million in Q2 2021.
- A 5-year average of $227.0 million and a median of $223.6 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2021 — Total Liabilities plunged 35.33% — and 2023, when it jumped 122.87%.
- Tracing AUTL's Total Liabilities over 5 years: stood at $92.2 million in 2021, then soared by 107.72% to $191.6 million in 2022, then surged by 37.74% to $263.9 million in 2023, then jumped by 34.67% to $355.4 million in 2024, then gained by 15.63% to $410.9 million in 2025.
- The last three Total Liabilities figures came in at $410.9 million (Q4 2025), $396.5 million (Q3 2025), and $374.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | 418.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 418.39 Mn |
| Dec 31, 2025 | 410.94 Mn |
| Sep 30, 2025 | 396.50 Mn |
| Jun 30, 2025 | 374.52 Mn |
| Mar 31, 2025 | 375.23 Mn |
| Dec 31, 2024 | 355.40 Mn |
| Sep 30, 2024 | 350.53 Mn |
| Jun 30, 2024 | 325.78 Mn |
| Mar 31, 2024 | 319.41 Mn |
| Dec 31, 2023 | 263.91 Mn |
| Sep 30, 2023 | 225.58 Mn |
| Jun 30, 2023 | 221.66 Mn |
| Mar 31, 2023 | 193.05 Mn |
| Dec 31, 2022 | 191.60 Mn |
| Sep 30, 2022 | 102.68 Mn |
| Jun 30, 2022 | 99.46 Mn |
| Mar 31, 2022 | 92.85 Mn |
| Dec 31, 2021 | 92.24 Mn |
| Sep 30, 2021 | 51.91 Mn |
| Jun 30, 2021 | 46.97 Mn |